Guo, S.;                     Bai, X.;                     Shi, S.;                     Deng, Y.;                     Kang, X.;                     An, H.    
        TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. Int. J. Mol. Sci. 2021, 22, 10930.
    https://doi.org/10.3390/ijms222010930
    AMA Style
    
                                Guo S,                                 Bai X,                                 Shi S,                                 Deng Y,                                 Kang X,                                 An H.        
                TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences. 2021; 22(20):10930.
        https://doi.org/10.3390/ijms222010930
    
    Chicago/Turabian Style
    
                                Guo, Shuai,                                 Xue Bai,                                 Sai Shi,                                 Yawen Deng,                                 Xianjiang Kang,                                 and Hailong An.        
                2021. "TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment" International Journal of Molecular Sciences 22, no. 20: 10930.
        https://doi.org/10.3390/ijms222010930
    
    APA Style
    
                                Guo, S.,                                 Bai, X.,                                 Shi, S.,                                 Deng, Y.,                                 Kang, X.,                                 & An, H.        
        
        (2021). TMEM16A, a Homoharringtonine Receptor, as a Potential Endogenic Target for Lung Cancer Treatment. International Journal of Molecular Sciences, 22(20), 10930.
        https://doi.org/10.3390/ijms222010930